Results 151 to 160 of about 131,929 (338)
In our central morphological review system, megakaryocyte counts are prioritized alongside BM cellularity to differentiate between AA and MDS. A retrospective analysis of patients with SAA and those with LR‐hMDS, registered in that system, revealed a significant difference in outcomes.
Tomoya Maeda+25 more
wiley +1 more source
Leukonychia Partialis in Kawasaki Disease [PDF]
Silvia Iosub, Donald S. Gromisch
openalex +1 more source
This study evaluated the potential of sulfur metabolites as biomarkers for esophageal cancer using blood and exhaled breath condensate (EBC) samples. Absolute quantification analysis revealed elevated levels of cysteine hydropersulfide (CysSSH) and homocysteine hydropersulfide (HomoCysSSH) in patients with esophageal cancer, with HomoCysSSH in plasma ...
Seji Asamitsu+13 more
wiley +1 more source
Abstract Aims/Introduction While studies on kidney disease (KD) in patients with severe metabolic syndrome (MetS) have been reported, research on undiagnosed MetS individuals is limited. This study aimed to investigate KD mechanisms in early MetS stages among Japanese individuals to establish accurate KD prediction models applicable to specific health ...
Chihaya Fukai+4 more
wiley +1 more source
916 IMMUNOREGULATORY ABNORMALITIES IN KAWASAKI DISEASE [PDF]
Raif S. Geha+6 more
openalex +1 more source
Abstract Aims To describe temporal changes in the characteristics of medication‐initiator cohorts in persons with chronic kidney disease (CKD) and type 2 diabetes (T2D). Materials and Methods Adults with CKD and T2D initiating sodium‐glucose cotransporter‐2 inhibitors (SGLT‐2i) or glucagon‐like peptide‐1 receptor agonists (GLP‐1RA) were identified in ...
Yuichiro Yano+9 more
wiley +1 more source
775 PROBABLE EFFICACY OF HIGH DOSE SALICYLATE IN REDUCING CORONARY INVOLVEMENT IN KAWASAKI DISEASE [PDF]
Gideon Koren+3 more
openalex +1 more source
Severe immune‐mediated adverse events requiring high‐dose corticosteroids associated with durvalumab and tremelimumab treatment did not affect the antitumor efficacy of this treatment in patients with unresectable hepatocellular carcinoma. Appropriate management of these adverse events is essential to guide sequential treatment. Abstract Aim Durvalumab
Takanori Ito+27 more
wiley +1 more source
Fixed point theorem in metric spaces and its application to the Collatz conjecture [PDF]
In this paper, we show the new fixed point theorem in metric spaces. Furthermore, for this fixed point theorem, we apply to the Collatz conjecture.
arxiv